Amf Tjanstepension Ab Bristol Myers Squibb CO Transaction History

Amf Tjanstepension Ab

$13.5 Billion
Q3 2024

A detailed history of Amf Tjanstepension Ab transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Amf Tjanstepension Ab holds 610,181 shares of BMY stock, worth $35 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

610,181

Previous 610,181 -0.0%

Holding current value

$35 Million

Previous $31.6 Million -0.0%

% of portfolio

0.23%

Previous 0.23%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$39.66 - $51.75 $1.56 Million - $2.04 Million	39,419 Added 6.91%	610,181 $31.6 Million
Q2 2024 Jul 10, 2024	BUY	$40.25 - $52.99 $1.78 Million - $2.35 Million	44,330 Added 8.42%	570,762 $23.7 Million
Q4 2023 Jan 30, 2024	SELL	$48.48 - $57.85 $499,586 - $596,144	-10,305 Reduced 1.92%	526,432 $27 Million
Q3 2023 Oct 26, 2023	SELL	$57.89 - $64.73 $19.7 Million - $22.1 Million	-340,843 Reduced 38.84%	536,737 $31.2 Million
Q1 2023 Apr 24, 2023	SELL	$65.71 - $74.53 $8.17 Million - $9.27 Million	-124,349 Reduced 12.41%	877,580 $60.8 Million
Q4 2022 Jan 26, 2023	BUY	$68.48 - $81.09 $23.6 Million - $27.9 Million	343,993 Added 52.28%	1,001,929 $0
Q3 2022 Oct 26, 2022	SELL	$0.13 - $76.84 $1,153 - $681,570	-8,870 Reduced 1.33%	657,936 $46.8 Million
Q2 2022 Jul 26, 2022	SELL	$72.62 - $79.98 $52.8 Million - $58.1 Million	-726,856 Reduced 52.15%	666,806 $51.5 Million
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $3.6 Million - $4.31 Million	58,521 Added 4.38%	1,393,662 $102 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $21 Million - $24.5 Million	-392,498 Reduced 22.72%	1,335,141 $83.3 Million
Q3 2021 Nov 03, 2021	SELL	$59.17 - $69.31 $27.1 Million - $31.7 Million	-457,288 Reduced 20.93%	1,727,639 $102 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $20 Million - $21.8 Million	-322,713 Reduced 12.87%	2,184,927 $146 Million
Q1 2021 Apr 28, 2021	BUY	$59.34 - $66.74 $1.9 Million - $2.14 Million	32,094 Added 1.3%	2,507,640 $159 Million
Q4 2020 Feb 02, 2021	BUY	$57.74 - $65.43 $22.4 Million - $25.4 Million	387,874 Added 18.58%	2,475,546 $154 Million
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $722,239 - $800,336	-12,576 Reduced 0.6%	2,087,672 $126 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $6.55 Million - $7.66 Million	-119,502 Reduced 5.38%	2,100,248 $123 Million
Q1 2020 Apr 14, 2020	BUY	$46.4 - $67.43 $9.69 Million - $14.1 Million	208,936 Added 10.39%	2,219,750 $124 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $22.5 Million - $29.4 Million	458,006 Added 29.5%	2,010,814 $129 Million
Q3 2019 Oct 29, 2019	SELL	$42.77 - $50.71 $13.2 Million - $15.7 Million	-309,369 Reduced 16.61%	1,552,808 $78.7 Million
Q2 2019 Jul 11, 2019	BUY	$44.62 - $49.34 $20 Million - $22.2 Million	448,945 Added 31.77%	1,862,177 $84.5 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $2.8 Million - $3.34 Million	-62,105 Reduced 4.21%	1,413,232 $67.4 Million
Q4 2018 Jan 30, 2019	SELL	$48.76 - $63.23 $13.8 Million - $17.9 Million	-283,705 Reduced 16.13%	1,475,337 $76.7 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $8.95 Million - $10.1 Million	-162,227 Reduced 8.44%	1,759,042 $109 Million
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $16.2 Million - $20.2 Million	-320,587 Reduced 14.3%	1,921,269 $106 Million
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $9.82 Million - $11.3 Million	-163,967 Reduced 6.82%	2,241,856 $142 Million
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $8.66 Million - $9.45 Million	144,554 Added 6.39%	2,405,823 $147 Million
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $125 Million - $144 Million	2,261,269	2,261,269 $144 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amf Tjanstepension Ab, based on Form 13F filings with the SEC.

News

Stay updated on Amf Tjanstepension Ab with notifications on news.

Account

Amf Tjanstepension Ab Bristol Myers Squibb CO Transaction History